Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Nov 30:1–10. Online ahead of print. doi: 10.1007/s40615-022-01468-3

Willingness to Receive the COVID-19 Vaccine in California: Disparities by Race and Citizenship Status

Adrian Matias Bacong 1,2,, Alein Y Haro-Ramos 3
PMCID: PMC9713137  PMID: 36449129

Abstract

Although it is widely acknowledged that racialized minorities may report lower COVID-19 vaccine willingness compared to non-Hispanic white individuals, what is less known, however, is whether the willingness to receive the COVID-19 vaccine also differs by citizenship. Understanding disparities in vaccine willingness by citizenship is particularly important given the misleading rhetoric of some political leaders regarding vaccine eligibility by citizenship status. This study used the 2020 California Health Interview Survey (n = 21,949) to examine disparities in vaccine willingness by race/ethnicity and citizenship among Asian, Latinx, and non-Hispanic white individuals. Overall, 77.7% of Californians indicated that they were willing to receive the COVID-19 vaccine if it was made available. However, there were distinct differences by race/ethnicity and citizenship. Asian people, regardless of citizenship, had the highest predicted probability of vaccine willingness, accounting for demographic, socioeconomic, and health factors. Non-citizen Latinx and non-citizen non-Hispanic white people had higher predicted probabilities of vaccine willingness compared to their US-born counterparts, accounting for demographic, socioeconomic, and health factors. Our results reveal that although vaccine willingness may be high among non-citizen individuals, it may not necessarily translate into actual vaccine uptake. Furthermore, while individual-level factors may account for some of the differences in vaccine willingness by race/ethnicity and citizenship, other institutional and structural barriers prevent vaccine uptake.

Keywords: COVID-19, Vaccination, Race/ethnicity, Citizenship, Health equity

Introduction

COVID-19 vaccine disparities in CA are evident by race/ethnicity, with Black and Latinx individuals experiencing lower vaccination rates than their White and Asian counterparts [1]. However, while racial disparities are well known, a paucity of research examines the degree to which racial subgroups of varying citizenship statuses fare in COVID-19 vaccine willingness. Immigrants and racialized minorities have an elevated risk of COVID-19 infection, morbidity, and mortality [2] due to social and occupational factors that lead to differential exposure, such as being employed in public-facing jobs in essential industries and low access to health care [3]. Given the multiple intertwining COVID-19 risk factors that vulnerable groups experience, it is crucial to understand whether beliefs and willingness regarding the COVID-19 vaccines among racialized minorities vary across immigration statuses.

Previous studies have found that even before the COVID-19 pandemic, immigrants experienced disparities in vaccination compared to those born in the USA [4]. For example, vaccination coverage was lower among foreign-born compared to US-born individuals in pneumococcal, HPV, and Tdap, even after accounting for confounding factors [4]. While vaccination rates were generally lower among foreign-born people, differences were starker among noncitizens, with Hispanic/Latinx noncitizens having the lowest coverage for several vaccines. Other work has also documented racial-ethnic disparities in vaccination rates for diseases like the flu, with the most pervasive disparities found between Black and Latinxs adults compared to Whites [5, 6]. Given the variation in vaccination rates, it is imperative to consider the attitudes toward the vaccine within citizenship status and by race/ethnicity.

Preexisting deterrents to preventive health care services, such as language barriers, financial limitations, and low health insurance rates [7, 8], are now compounded by a turbulent US political environment [9], mistrust in health care in marginalized communities [10], and the novelty of the COVID-19 vaccine [11]. In particular, the implementation of the new public charge rule, which went into effect just before the pandemic began in February 2020, led to a decline in enrollment in safety-net programs (i.e., Medicaid, WIC, and SNAP) among US-born children, particularly in regions with a higher share of noncitizens. Specifically, 260,000 fewer people were covered in children’s Medicaid coverage occurred after the public charge announcement by then-President Donald Trump [12]. This specific public charge rule broadened the criteria by which noncitizen immigrants could become ineligible for permanent resident status. In this case, any nonpermanent resident immigrant could be denied permanent residency if they received public benefits such as food assistance, housing, or Medicaid [12]. Given that the public charge rule was implemented a month before the national state of emergency went into effect, it is plausible that immigrants without legal status may have feared accessing health care and preventive services, including immunization against SARS-CoV2.

Along with the political environment, organizational barriers to getting vaccinated have been cited at vaccination sites nationwide. While the COVID-19 vaccine is free and accessible to everyone regardless of health insurance or legal status [13], various businesses administering the vaccine require patients to provide a Social Security number or health insurance information [14]. The resulting obstacles are more consequential for vulnerable subgroups, such as undocumented immigrants, who are less likely to advocate for themselves.

Overall, there is a need for a more comprehensive understanding of the willingness and attitudes toward the COVID-19 vaccine among racial minorities of distinct citizenship statuses. These data can inform the tailoring of vaccination programs and communication strategies to improve vaccination uptake among marginalized communities at the intersection of race/ethnicity and citizenship status. To address these gaps, this study examines differences in the willingness to receive the COVID-19 vaccine by citizenship status and race/ethnicity among a representative sample of Californians.

Methods

We used data from the public use 2020 California Health Interview Survey (CHIS) (n = 21,949). The CHIS is an annual survey intended to provide state-wide estimates of the health, social, and economic profiles of all Californians. The 2020 CHIS is a particularly novel dataset to study the effects of the COVID-19 pandemic because it was immediately redesigned during CA’s “work from home” orders to include questions about the effects of the pandemic [15]. The redesign of the questionnaire at the onset of the pandemic allowed the CHIS to provide real-time data on the social and health effects of the pandemic. We restrict our data to the 2020 iteration as it is the most currently available data of the CHIS. Of the 21,949 people who completed the 2020 CHIS, we restrict our analysis to 20,536 individuals who had complete data on all of the variables of interest outlined below. Since these data are de-identified, public use data, they are not human subjects research and do not require Institutional Review Board approval.

Outcome

Vaccine willingness was our outcome variable of interest and was asked as follows: “If a vaccine becomes available for COVID-19, would you get it?” Two response categories were available and were coded as 0 = no and 1 = yes.

Independent Variable

Participants’ race/ethnicity and citizenship status were the independent variable of interest. The CHIS provides separate variables for participants’ self-identified race/ethnicity and citizenship status. We combined both variables to create the following nine categories: “0 = US-born White,” “1 = naturalized White,” “2 = non-citizen White,” “3 = US-born Latinx,” “4 = naturalized Latinx,” “5 = noncitizen Latinx,” “6 = US-born Asian,” “7 = naturalized Asian,” and “8 = noncitizen Asian.” In our preliminary analyses, we attempted to examine vaccine willingness among Black and African American people, American Indian and Alaska Native people, Native Hawaiians, and Pacific Islander people, in addition to people who identified as “other races” or as “multiracial.” However, sample sizes for certain groups (e.g., noncitizen Black) were small, thereby leading to unstable estimates. We acknowledge that this is a limitation of this study and that more work is needed to include those who do not identify as non-Hispanic White, Latino, or Asian.

Covariates

We account for four sets of covariates that could explain the association between vaccine uptake, race/ethnicity, and citizenship. Our demographic factors included age category (18–34 years old, 35–49 years old, 50–64 years old, and 65 + years old) and gender (female or male). Given privacy concerns, the public-use version of the CHIS did not provide additional categories for other gender identities.

Social and socioeconomic factors included family type (single with no kids, married with no kids, married with kids, and single with kids), urbanicity (urban or rural), educational attainment (less than high school, high school graduate, some college, associate’s degree, bachelor’s degree, or more), employment status (currently employed versus not), and whether participants had a usual source of care other than the emergency room. We also examined the federal poverty level (FPL) but only presented its distribution in the univariate and bivariate analyses (> 100% FPL vs. not) due to issues of collinearity with other socioeconomic predictors.

We examined three types of COVID-19-related factors: whether participants experienced racial discrimination due to the COVID-19 pandemic, whether participants work in “essential work,” and whether participants worked from home due to the COVID-19 pandemic.

Finally, we examined physical health factors that could influence vaccine uptake. These factors included whether participants were overweight or obese, were diagnosed with diabetes, were diagnosed with heart disease, or were diagnosed as pre-hypertensive/hypertensive according to their doctor.

Analysis Plan

We began our analysis by first examining the weighted univariate distribution of vaccine uptake, demographic, social, socioeconomic, COVID-19, and health factors. Next, we examined the characteristics of the sample by race/ethnicity and citizenship status. Differences in each factor by race/ethnicity and citizenship were determined using a chi-square test. For our multivariable analyses, we examined a series of five nested binary logistic regressions. Model 1 examined the bivariate relationship between vaccine willingness and race/ethnicity and citizenship status. Model 2 introduced demographic factors as possible confounders in the association between vaccine willingness and race/ethnicity and citizenship status. Model 3 included social and socioeconomic factors as alternative explanatory variables for differences in vaccine willingness. Model 4 examined the additional associations of COVID-19-related factors as explanatory factors for vaccine willingness. Finally, model 5 included health factors as additional confounding factors. To provide ease of interpretation in disparities in vaccine willingness by race/ethnicity and citizenship status, we calculated predicted probabilities using the “margins” command in Stata. We also conduct pairwise comparisons of predicted probabilities by race/ethnicity and citizenship status using the “pwcompare” command in Stata and adjust for multiple comparisons using the Sidak method [16]. All data cleaning, recoding, and analysis were done using Stata Version 17.0 [17]. All analyses were weighted to be representative of the Californian population using the methods recommended by CHIS [18]. To summarize, these weights account for both the telephone and web data collection methods used by the CHIS in addition to the oversampling of certain minoritized groups to provide estimates for all counties, large and small, in CA. Furthermore, the weighting procedure accounts for the differential probability of selection of households, nonresponse, and sample differences among less-represented groups. Weights are based on 2010 Census stratum counts projections. Weighted analyses with the CHIS use Jackknife variance estimation calculation with replicate weights in order to produce reliable estimates that are representative of the Californian population [18].

Results

Table 1 presents the weighted sample characteristics of the 2020 CHIS. Overall, 77.7% of participants indicated that they would receive the COVID-19 vaccine if it was available. However, there were distinct differences in vaccine willingness by race and citizenship status (p < 0.001). In general, vaccine willingness was highest among US-born people within each race/ethnic group, except for Hispanic/Latinx people, where vaccine willingness was highest among noncitizen Hispanic/Latinx people. When examining differences in vaccine willingness by race/ethnicity, Asian people had the highest vaccine willingness, followed by non-Hispanic White and Hispanic/Latinx respondents. Interestingly, vaccine willingness was lowest among naturalized Hispanic/Latinx people.

Table 1.

Weighted sample characteristics by race and citizenship status, 2020 California Health Interview Survey (CHIS), n = 20,536

Asian Hispanic/Latinx Non-Hispanic White
Total (n = 20,536) US-born (n = 870) Naturalized (n = 1438) Non-citizen (n = 437) US-born (n = 2769) Naturalized (n = 1049) Non-citizen (n = 499) US-born (n = 12,452) Naturalized (n = 793) Non-citizen (n = 229)
Variables % % % % % % % % % % P-value
Would get COVID-19 vaccine if available 77.7 89.6 86.1 83.8 70.4 69.2 71.6 82.1 81.1 87.8  < 0.001
Demographic factors
Age category  < 0.001
18–34 years 30.6 56.6 11.1 47.0 53.6 15.0 26.1 22.2 18.5 27.8
35–49 years 25.2 23.3 27.2 29.6 24.6 26.4 42.4 20.6 19.2 41.1
50–64 years 23.3 10.6 33.9 18.8 12.5 36.5 25.9 25.4 27.0 12.9
65 + years 20.9 9.6 27.8 4.6 9.3 22.1 5.6 31.8 35.3 18.2
Female gender 50.8 56.0 54.4 45.5 49.8 51.0 51.2 51.1 44.8 49.6 0.033
Social factors
Family type  < 0.001
Single, no kids 39.6 59.5 27.8 36.3 46.5 27.0 24.8 43.4 34.7 30.4
Married, no kids 30.5 18.9 43.4 23.2 16.4 38.3 22.9 37.1 45.7 35.2
Married with kids 20.4 15.3 25.5 32.5 18.5 25.0 34.7 15.3 17.7 30.2
Single with kids 9.5 6.2 3.3 8.0 18.6 9.7 17.7 4.2 2.0 4.3
Living in rural area 11.7 3.2 5.3 3.5 9.3 8.6 11.5 17.6 6.8 3.7  < 0.001
Socioeconomic factors
Educational attainment  < 0.001
Less than high school 16.0 2.6 18.0 16.5 10.8 43.9 55.0 3.7 15.5 9.0
High school graduate 21.6 7.1 12.8 14.5 27.5 22.1 22.5 22.3 14.3 12.4
Some college 15.9 15.5 8.8 8.5 21.2 12.4 11.3 17.0 13.7 12.7
Associates degree 5.5 4.5 4.3 2.2 8.4 3.0 1.0 6.2 4.4 2.4
Bachelor’s degree or more 41.0 70.3 56.2 58.2 32.1 18.6 10.2 50.9 52.2 63.6
Currently employed 55.0 63.7 54.9 55.1 57.0 55.0 58.6 52.2 51.0 59.4 0.003
FPL >  = 100% 86.5 91.3 90.2 79.4 81.8 79.9 70.4 93.4 93.1 96.9  < 0.001
Has usual source of care 76.0 81.8 91.3 76.0 81.0 83.9 71.7 89.3 90.2 81.9  < 0.001
COVID-19-related factors
Experience discrimination based on race and COVID-19 1.6 7.2 2.7 3.8 1.8 0.8 3.0 0.6 0.3 0.6  < 0.001
Works as an “essential worker” 17.3 17.1 12.8 12.1 22.5 18.7 19.0 15.4 10.0 9.6  < 0.001
Works from home 22.2 41.1 24.4 27.3 23.2 14.2 7.1 24.6 18.8 28.2  < 0.001
Physical health factors
Overweight or obese 61.3 42.9 39.5 43.7 68.3 73.2 78.3 57.9 58.4 50.2  < 0.001
Diabetes diagnosed by doctor 10.7 4.6 15.6 8.2 9.9 19.5 12.7 8.6 7.8 5.9  < 0.001
Heart disease diagnosed by doctor 6.5 3.2 5.8 1.3 3.6 5.1 2.9 10.2 9.0 8.6  < 0.001
Prehypertension or hypertension diagnosed by doctor 32.1 26.0 39.7 18.9 25.8 35.4 23.8 36.8 40.7 29.3  < 0.001

FPL, federal poverty level

The majority of the sample was between 18 and 34 years old (30.6%), female (50.8%), and single without kids (39.6%). For socioeconomic factors, most participants had at least a bachelor’s degree (41.0%), were currently employed (55.0%), and had a usual source of healthcare other than the emergency room (76.0%). Approximately 1.6% of the sample indicated that they had experienced discrimination based on their race within the context of the COVID-19 pandemic, yet US-born Asian respondents were 3.5 times more likely to report experiences of racial discrimination during the pandemic (7.2%). Moreover, while 17.3% of all participants indicated that they were “essential workers,” US-born Latinxs were more likely (22.5%) to report being “essential workers.” Approximately 22.2% of participants indicated that they worked from home, yet noncitizen Latinxs were less likely to report being able to work from home (7.1%).

Table 2 presents the weighted binary logistic regression results of the association of vaccine willingness and citizenship status and race/ethnicity. In the crude bivariate model (model 1), all Hispanic/Latinx groups had lower odds of COVID-19 vaccine willingness compared to US-born non-Hispanic White people. In comparison, noncitizen White (OR = 1.57, 95% CI = 1.10, 2.25), US-born (OR = 1.87, 95% CI = 1.45, 2.43) and naturalized Asian (OR = 1.35, 95% CI = 1.06, 1.72) people had higher odds of COVID-19 vaccine willingness compared to US-born White people.

Table 2.

Weighted multivariable binary logistic regression of COVID-19 vaccine willingness on immigration status and race, 2020 California Health Interview Survey (n = 20,536)

Model 1 Model 2 Model 3 Model 4 Model 5
Variables OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Citizenship status and race
  US-born White Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
  Naturalized White 0.94 0.69–1.28 0.91 0.67–1.24 0.94 0.69–1.29 0.97 0.70–1.33 0.98 0.71–1.35
  Noncitizen White 1.57* 1.10–2.25 1.66** 1.15–2.39 1.62* 1.11–2.35 1.65** 1.14–2.38 1.62* 1.12–2.35
  US-born Latinx 0.52*** 0.46–0.59 0.56*** 0.49–0.63 0.66*** 0.58–0.76 0.67*** 0.58–0.77 0.67*** 0.58–0.77
  Naturalized Latinx 0.49*** 0.42–0.58 0.51*** 0.43–0.59 0.76** 0.64–0.92 0.77** 0.64 –0.93 0.76** 0.64–0.92
  Noncitizen Latinx 0.55*** 0.44–0.68 0.60*** 0.48–0.76 1.09 0.85–1.40 1.14 0.89–1.47 1.15 0.90–1.47
  US-born Asian 1.87*** 1.45–2.43 2.05*** 1.55–2.70 1.80*** 1.37–2.37 1.78*** 1.34–2.34 1.74*** 1.32–2.29
  Naturalized Asian 1.35* 1.06–1.72 1.38** 1.09–1.75 1.44** 1.14–1.83 1.46** 1.15–1.85 1.41** 1.11–1.79
  Noncitizen Asian 1.13 0.79–1.60 1.22 0.86–1.74 1.37 +  0.95–1.97 1.39 +  0.97–2.00 1.36 +  0.95–1.95
Demographic factors
Age category
  18–34 years old Ref Ref Ref Ref Ref Ref Ref Ref
  35–49 years old 0.96 0.82–1.12 1.02 0.87–1.19 1.02 0.88–1.20 1.02 0.87–1.18
  50–64 years old 1.00 0.85–1.19 1.10 0.92–1.31 1.13 0.94–1.34 1.09 0.91–1.30
  65 + years old 1.42*** 1.20–1.68 1.62*** 1.37–1.92 1.72*** 1.45–2.04 1.59*** 1.33–1.90
Gender
  Male Ref Ref Ref Ref Ref Ref Ref Ref
  Female 0.80*** 0.71–0.89 0.78*** 0.70–0.87 0.77*** 0.69–0.86 0.77*** 0.69–0.86
Social and socioeconomic factors
Family type
  Single, no kids Ref Ref Ref Ref Ref Ref
  Married, no kids 0.95 0.81–1.11 0.95 0.81–1.11 0.95 0.82–1.11
  Married with kids 0.76** 0.62–0.92 0.75** 0.62–0.91 0.77** 0.63–0.93
  Single with kids 1.08 0.88–1.32 1.08 0.89–1.32 1.10 0.90–1.33
Urbanicity
  Urban Ref Ref Ref Ref Ref Ref
  Living in rural area 0.81** 0.72–0.92 0.83** 0.73–0.94 0.84** 0.74–0.95
Educational attainment
  Less than high school Ref Ref Ref Ref Ref Ref
  High school graduate 1.49** 1.18–1.89 1.50** 1.18–1.91 1.51*** 1.19–1.92
  Some college 1.54*** 1.26–1.89 1.51*** 1.24–1.85 1.53*** 1.25–1.87
  Associates degree 1.78*** 1.39–2.28 1.74*** 1.35–2.23 1.75*** 1.36–2.26
  Bachelor’s degree or more 3.17*** 2.57–3.91 2.88*** 2.33–3.56 2.91*** 2.34–3.61
Employment status
  Currently unemployed Ref Ref Ref Ref Ref Ref
  Currently employed 0.96 0.86–1.08 0.91 0.80–1.03 0.92 0.80–1.04
  Has usual source of care
  Does not have usual source of care Ref Ref Ref Ref Ref Ref
  Has usual source of care 1.29** 1.08–1.54 1.27** 1.07–1.52 1.26* 1.05–1.51
COVID-related factors
Experience of discrimination based on race and COVID-19
  Did not experience discrimination based on race and COVID-19 Ref Ref Ref Ref
  Experienced discrimination based on race and COVID-19 0.95 0.61–1.48 0.96 0.61–1.49
Essential worker status
  Not an “essential worker” Ref Ref Ref Ref
  Works as an “essential worker” 1.03 0.88–1.21 1.03 0.87–1.20
Work from home status due to COVID-19
  Does not work at home Ref Ref Ref Ref
  Works at home due 1.52*** 1.31–1.77 1.52*** 1.31–1.77
Health-related factors
Weight status
  Not overweight or obese Ref Ref
  Overweight or obese 0.89 +  0.78–1.01
Diabetes status
  No diabetes diagnosed by doctor Ref Ref
  Diabetes diagnosis by doctor 1.36** 1.11–1.66
  Heart disease status
  No heart disease diagnosed by doctor Ref Ref
  Heart disease diagnosed by doctor 1.08 0.84–1.39
Hypertension status
  No pre-hypertension/hypertension diagnosed by doctor Ref Ref
  Pre-hypertension/hypertension diagnosed by doctor 1.04 0.92–1.17
  Constant 4.59*** 4.28–4.92 4.71*** 4.04–5.49 1.89*** 1.42–2.52 1.84*** 1.38–2.46 1.93*** 1.42–2.62

 + , p < 0.10, *, p < 0.05, **, p < 0.01, and ***, p < 0.001. Ref., reference category

Model 2, which included age category and gender as demographic confounders, showed similar results to model 1. Hispanic/Latinx groups, regardless of citizenship, continued to have lower odds of vaccine willingness compared to US-born White individuals. US-born and naturalized Asian people continued to have higher odds of vaccine willingness compared to US-born White people.

Results remained similar when accounting for social and socioeconomic factors (model 3), with a couple of exceptions. Non-citizen Latinx people now had similar odds of vaccine willingness when compared to US-born White people. Following US-born and naturalized Asian people, Non-citizen Asian people had marginally higher odds of vaccine willingness when compared to US-born White people (OR = 1.37, 95% CI = 0.95, 1.97). These trends seen for all groups remained robust when accounting for COVID-19-related factors (model 4) and health factors (model 5).

Figure 1 presents a visualization of the predicted probabilities of vaccine hesitancy by race and citizenship status (based on Table 2, model 5, fully adjusted for demographic, social, socioeconomic, COVID-19, and health factors). In addition, we conducted pairwise comparisons to evaluate if differences in the predicted probability of vaccine willingness by race and citizenship status group were statistically significant using the Sidak method. In general, we see that vaccine willingness is similar among all Asian people regardless of citizenship status (US-born vs. naturalized Asian: p = 1.000; US-born vs. noncitizen Asian: p = 1.000; naturalized vs. non-citizen Asian: p = 1.000) In contrast, there are distinct differences between US-born and non-citizen groups for non-Hispanic White and Latinx groups. Starting with Latinx people first, we see that vaccine willingness is significantly higher among noncitizen Latinx people than among US-born Latinx (p = 0.010). A similar trend is seen between noncitizens and US-born non-Hispanic White. Noncitizen White individuals had higher vaccine willingness than US-born White individuals, albeit not statistically significant when accounting for multiple comparisons (p = 0.328).

Fig. 1.

Fig. 1

Predicted probability of willingness to obtain COVID-19 vaccine by citizenship status and race. Note: Based on model 5 of Table 2, fully adjusted for demographic, social, socioeconomic, COVID-19, and health factors

When comparing race/ethnic and citizenship groups, US-born Asian people had significantly higher vaccine willingness compared to US-born White (p = 0.006), US-born Latinx people (p < 0.001), and naturalized Latinx (p < 0.001). In addition, naturalized Asian (p < 0.001) and noncitizen Asian (p = 0.019) people had significantly higher vaccine willingness compared to US-born Latinx. Finally, noncitizen White people had higher vaccine willingness compared to US-born Latinx (p = 0.001) and naturalized Latinx (p = 0.014). Overall, vaccine willingness was lowest among US-born Latinx people, while vaccine willingness was highest among US-born Asian and non-citizen White people.

Discussion

Our results reveal the varied disparities in COVID-19 vaccine willingness by both race/ethnicity and citizenship status. Overall, we found that at least 70% of Californians were willing to receive the COVID-19 vaccine when it became available. However, there were distinct differences by race and citizenship status. Asian people had the highest predicted probability of willingness to receive the COVID-19 vaccine, regardless of citizenship status, followed by non-Hispanic white and Latinx individuals. Furthermore, noncitizen Latinx and White individuals had a greater predicted probability of willingness to receive the COVID-19 vaccine relative to their naturalized and US-born counterparts.

Although the high willingness to become vaccinated among all Californians, regardless of citizenship, is encouraging, this willingness may not translate into actual vaccine uptake. As of July 2022, 71.5% of all Californians have been fully vaccinated for COVID-19 (i.e., 2 doses of Moderna or Pfizer or 1 dose of Johnson & Johnson) [1]. However, only 58.1% of Californians have received their first booster dose. Thus, it is possible that some of the disparities in vaccine uptake may be related to barriers that noncitizen or racially marginalized individuals may face, such as the threat of being labeled a public charge or the inability to get a vaccine because of demanding work schedules.

The higher vaccine willingness among Asian people is particularly interesting. The conflation of COVID-19 to Asian people [1921] would lead some Asian people to be more willing to receive the vaccine to combat these stereotypes. Furthermore, the higher rates of vaccine willingness may be related to the presence of Asian people in essential work and healthcare. For example, although Asian people comprise about 7% of all healthcare workers [22] there has been disproportionate COVID-19 infection and mortality among certain Asian ethnic groups, like Filipinos, who disproportionately comprise a large share of the nursing workforce [23, 24].

The lower vaccine willingness among Latinx individuals as a whole is also concerning, especially given that Latinx immigrants comprise a large share of the essential workforce. These lower rates of willingness to get vaccinated may be related to institutional and structural barriers for workers that may not allow Latinx immigrants to take paid time off to receive the vaccine. For example, Latinx immigrants are more likely to work in precarious industries where employer abuse is pervasive [25] and taking time off from work is difficult [26]. Another explanation may be Latinx Californians’ fear of immigration enforcement and becoming a public charge. For instance, a recent study found that exposures to immigration enforcement, such as avoidance of health and social services due to immigration fears or experiences of detention or deportation, were associated with a lower likelihood of accepting the COVID-19 vaccine among a sample of undocumented young adults in CA [27]. Alternatively, some Latinx people may have a general mistrust due to discrimination by medical providers or histories of racial discrimination [22, 28, 29]. Thus, although vaccine willingness may be slightly higher among non-citizen Latinx compared to US-born and naturalized Latinx people, structural barriers may ultimately affect the actual uptake of the COVID-19 vaccine.

Finally, while the willingness to receive the COVID-19 vaccine was generally high among non-Hispanic White individuals, it was interesting to see that rates were lowest among US-born Whites, despite accounting for educational attainment. The lower willingness rates among US-born individuals, in general, could be related to potential political views on vaccination. In the USA, race/ethnicity has become a key predictor of voting behavior and political affiliation, whereby White voters are more likely to lean Republican [30]. Given the politicization of the COVID-19 pandemic, political views are a significant factor in vaccine resistance. For instance, political ideology is associated with vaccine uptake, whereby regions with a higher share of Republicans have a lower share of individuals who have received the COVID-19 vaccine [30, 31]. Unfortunately, the 2020 CHIS did not include questions related to political preferences.

These results are balanced by a number of additional limitations. First, as previously mentioned in our methods, we were unable to examine vaccine willingness disparities among Black, Indigenous, Native Hawaiian, Pacific Islander, and multi-racial populations. Previous work has noted the disheartening toll that COVID-19 has had among these communities [32, 33], which may encourage these communities to be more willing to receive the COVID-19 vaccine. However, future work should examine how issues of citizenship and immigration affect the Black community, especially.

Second, given our use of public data, we are unable to examine how vaccine willingness may differ within ethnic subgroups (e.g., Mexican and Filipino). Although we provide our reports in the aggregate, it is possible that vaccine willingness may vastly differ between certain subgroups depending on the impact COVID-19 has had on them.

Finally, there may be some other unmeasured factors that we were unable to account for in our analysis. As previously mentioned, we were unable to examine the role that political preferences or policies such as “public charge” may have in explaining differences in vaccine willingness by race and citizenship. Furthermore, while CHIS is intended to be representative of all of CA, we are unable to examine how larger area-level factors could affect vaccine willingness.

However, this study provides two key contributions to the literature on COVID-19 vaccine health inequities by race, ethnicity, and citizenship. First, although previous studies have examined COVID-19 inequities by race and ethnicity [10, 11, 28] or have speculated how there may be disparities by citizenship [8, 9, 12, 27, 34], our study provides a detailed look at how willingness to vaccinate may be different by race/ethnicity and citizenship. Examining the intersections of race, ethnicity, and citizenship allows us to examine how potential vulnerability compounds to produce health inequities [35]. Second, our results provided the first look into the general willingness of individuals to become vaccinated against COVID-19 prior to vaccination is available. This is important as the USA continues to deal with upsurges in COVID-19 and future outbreaks.

Conclusion

Overall, our study found that COVID-19 vaccine willingness at the beginning of the pandemic among Asian, Latinx, and non-Hispanic White individuals was high. However, there were distinct differences by citizenship status. Although the high rates of willingness to receive the COVID-19 vaccine are encouraging, they may not translate into actual uptake. As booster doses and COVID-19 antiviral treatment (i.e., Paxlovid) become available, it is important to consider some of the large institutional and structural barriers that may prevent vaccine willingness from becoming vaccine uptake. Finally, it is important to remove these barriers to ensure that vaccine uptake is equitable for all.

Author Contribution

AMB conceptualized the study, led the data analysis and interpretation, wrote the methods, results, discussion, and conclusion, and prepared the manuscript for submission. AYHR supported AMB in the data analysis and interpretation, wrote the introduction, and edited the manuscript for clarity.

Funding

Adrian M. Bacong was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under award number F31MD015931. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Declarations

Ethics Approval

Because this study is an observational study using de-identified public use data, it does not fit the definition of “human subjects research.” Thus, institutional review board approval was not required.

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.California Department of Public Health. Statewide vaccination data [Web]. 2022 [updated July 7, 2022; cited 2022 July 13, 2022]. Available from: https://covid19.ca.gov/vaccination-progress-data/.
  • 2.Hayward SE, Deal A, Cheng C, Crawshaw A, Orcutt M, Vandrevala TF, et al. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: a systematic review. J Migr Health. 2021;3:100041. doi: 10.1016/j.jmh.2021.100041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Ojeda RH, Robinson S, Dominguez-Villegas R, Telles E, Valenzuela A, Aguilar J. Undocumented during COVID-19: essential for the economy but excluded from relief. Print. Los Angeles, CA: UCLA Latino Policy & Policis Initiative, 2020.
  • 4.Lu P-J, Rodriguez-Lainz A, O’Halloran A, Greby S, Williams WW. Adult vaccination disparities among foreign-born populations in the U.S., 2012. Am J Prev Med. 2014;47(6):722–33. doi: 10.1016/j.amepre.2014.08.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Vupputuri S, Rubenstein KB, Derus AJ, Loftus BC, Horberg MA. Factors contributing to racial disparities in influenza vaccinations. PLoS One. 2019;14(4):e0213972. doi: 10.1371/journal.pone.0213972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Granade CJ, Lindley MC, Jatlaoui T, Asif AF, Jones-Jack N. Racial and ethnic disparities in adult vaccination: a review of the state of evidence. Health Equity. 2022;6(1):206–223. doi: 10.1089/heq.2021.0177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hacker K, Anies M, Folb BL, Zallman L. Barriers to health care for undocumented immigrants: a literature review. Risk Manag Healthcare Policy. 2015;8:175–183. doi: 10.2147/rmhp.S70173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Capps R, Gelatt J. Barriers to COVID-19 testing and treatment: immirants without health coverage in the United States. Migration Policy Institute, 2020 May 2020. Report No.
  • 9.Page KR, Venkataramani M, Beyrer C, Polk S. Undocumented U.S. immigrants and COVID-19. N Engl J Med. 2020;382(21):e62. doi: 10.1056/NEJMp2005953. [DOI] [PubMed] [Google Scholar]
  • 10.Carson SL, Casillas A, Castellon-Lopez Y, Mansfield LN, Morris DA, Barron J, et al. COVID-19 vaccine decision-making factors in racial and ethnic minority communities in Los Angeles, California. JAMA Netw Open. 2021;4(9):e2127582–e. doi: 10.1001/jamanetworkopen.2021.27582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gerretsen P, Kim J, Caravaggio F, Quilty L, Sanches M, Wells S, et al. Individual determinants of COVID-19 vaccine hesitancy. PLoS One. 2021;16(11):e0258462. doi: 10.1371/journal.pone.0258462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Barofsky J, Vargas A, Rodriguez D, Barrows A. Spreading fear: the announcement of the public charge rule reduced enrollment in child safety-net programs. Health Aff. 2020;39(10):1752–1761. doi: 10.1377/hlthaff.2020.00763. [DOI] [PubMed] [Google Scholar]
  • 13.Department of Homeland Security. DHS statement on equal access to COVID-19 vaccines and vaccine distribution sites [Web]. Washington D.C., USA: Department of Homeland Security; 2021 [updated February 1st, 2022; cited 2022 May 2nd, 2022]. Available from: https://www.dhs.gov/news/2021/02/01/dhs-statement-equal-access-covid-19-vaccines-and-vaccine-distribution-sites.
  • 14.Chen C, Jameel M. False barriers: these things should not prevent you from getting a COVID vaccine [Web]. ProPublica; 2021 [updated April 1, 2021; cited 2022 July 16, 2022]. Available from: https://www.propublica.org/article/false-barriers-these-things-should-not-prevent-you-from-getting-a-covid-vaccine?token=ASpasYsnRLZBao6tP1YQDxB_gscD9o6O.
  • 15.Ponce NA, Paycao D, Wells BM, Park R, Hughes T. COVID-19 rapid response: how the California Health Interview Survey adapted during the global pandemic. Am J Public Health. 2021;111(12):2122–2126. doi: 10.2105/ajph.2021.306518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Midway S, Robertson M, Flinn S, Kaller M. Comparing multiple comparisons: practical guidance for choosing the best multiple comparisons test. PeerJ. 2020;8:e10387. doi: 10.7717/peerj.10387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.StataCorp. Stata statistical software: release 17. College Station, TX: StataCorp LLC; 2021.
  • 18.California Health Interview Survey . CHIS 2019–2020 methodology series: report 5 - weighting and variance estimation. Los Angeles, CA: UCLA Center for Health Policy Research; 2021. [Google Scholar]
  • 19.Hswen Y, Xu X, Hing A, Hawkins JB, Brownstein JS, Gee GC. Association of “#covid19” versus “#chinesevirus” with anti-asian sentiments on Twitter: March 9–23, 2020. Am J Public Health. 2021;111(5):956–964. doi: 10.2105/ajph.2021.306154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hohl A, Choi M, Horse AJY, Medina RM, Wan N, Wen M. Spatial distribution of hateful tweets against Asians and Asian Americans during the COVID-19 pandemic, November 2019 to May 2020. Am J Public Health. 2022;112(4):646–649. doi: 10.2105/ajph.2021.306653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Li Y, Nicholson HL., Jr When “model minorities” become “yellow peril”—othering and the racialization of Asian Americans in the COVID-19 pandemic. Sociol Compass. 2021;15(2):e12849. doi: 10.1111/soc4.12849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Artiga S, Rae M, Pham O, Hamel L, Munana C. COVID-19 risks and impacts among health care workers by race/ethnicity. Kaiser Fam Found 2022.
  • 23.Nazareno J, Yoshioka E, Adia AC, Restar A, Operario D, Choy CC. From imperialism to inpatient care: work differences of Filipino and White registered nurses in the United States and implications for COVID-19 through an intersectional lens. Gend Work Organ. 2021;28(4):1426–1446. doi: 10.1111/gwao.12657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sabado-Liwag MD, Manalo-Pedro E, Taggueg R, Bacong AM, Adia AC, Demanarig D, et al. Addressing the interlocking impact of colonialism and racism on Filipinx/a/o American health inequities. Health Aff. 2022;41(2):289–295. doi: 10.1377/hlthaff.2021.01418. [DOI] [PubMed] [Google Scholar]
  • 25.Haro AY, Kuhn R, Rodriguez MA, Theodore N, Melendez E, Valenzuela A. Beyond occupational hazards: abuse of day laborers and health. J Immigr Minor Health. 2020;22(6):1172–1183. doi: 10.1007/s10903-020-01094-3. [DOI] [PubMed] [Google Scholar]
  • 26.Ibarra AB. Eager to be vaccinated, California farmworkers face obstacles [Web]. Cal Matters; 2021 [updated September 28, 2021; cited 2022 July 16, 2022]. Available from: https://calmatters.org/health/coronavirus/2021/03/california-farmworkers-vaccine-obstacles/.
  • 27.Sudhinaraset M, Nwankwo E, Choi HY. Immigration enforcement exposures and COVID-19 vaccine intentions among undocumented immigrants in California. Prev Med Rep. 2022;27:101808. doi: 10.1016/j.pmedr.2022.101808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Oronce CIA, Adia AC, Ponce NA. US health care relies on Filipinxs while ignoring their health needs: disguised disparities and the COVID-19 pandemic. JAMA Health Forum. 2021;2(7):e211489–e. doi: 10.1001/jamahealthforum.2021.1489. [DOI] [PubMed] [Google Scholar]
  • 29.Savoia E, Piltch-Loeb R, Goldberg B, Miller-Idriss C, Hughes B, Montrond A, et al. Predictors of COVID-19 vaccine hesitancy: socio-demographics, co-morbidity, and past experience of racial discrimination. Vaccines. 2021;9(7):767. doi: 10.3390/vaccines9070767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Albrecht D. Vaccination, politics and COVID-19 impacts. BMC Public Health. 2022;22(1):96. doi: 10.1186/s12889-021-12432-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Agarwal R, Dugas M, Ramaprasad J, Luo J, Li G, Gao G. Socioeconomic privilege and political ideology are associated with racial disparity in COVID-19 vaccination. Proc Natl Acad Sci. 2021;118(33):e2107873118. doi: 10.1073/pnas.2107873118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wang D, Gee GC, Bahiru E, Yang EH, Hsu JJ. Asian-Americans and Pacific Islanders in COVID-19: emerging disparities amid discrimination. J Gen Intern Med. 2020;35(12):3685–3688. doi: 10.1007/s11606-020-06264-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Yellow Horse AJ, Yang T-C, Huyser KR. Structural inequalities established the architecture for COVID-19 pandemic among Native Americans in Arizona: a geographically weighted regression perspective. J Racial Ethn Health Disparities. 2022;9(1):165–175. doi: 10.1007/s40615-020-00940-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Sohn H, Aqua JK. Geographic variation in COVID-19 vulnerability by legal immigration status in California: a prepandemic cross-sectional study. BMJ Open. 2022;12(5):e054331. doi: 10.1136/bmjopen-2021-054331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bacong AM, Menjívar C. Recasting the immigrant health paradox through intersections of legal status and race. J Immigr Minor Health. 2021;23(5):1092–1104. doi: 10.1007/s10903-021-01162-2. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Racial and Ethnic Health Disparities are provided here courtesy of Nature Publishing Group

RESOURCES